Malawi launched Option Bþ, a program for all pregnant or breastfeeding HIV-positive women to begin lifelong combination antiretroviral therapy (cART), in July 2011. This study characterises a portion of the continuum of care within an antenatal setting in Lilongwe. Women testing HIV-positive and having a cART initiation record at Bwaila Antenatal Clinic from July 2013 to January 2014 were included. Using logistic regression models, we analysed relationships between maternal characteristics and return for infant testing. Among 490 HIV-positive women with a cART initiation record, 360 (73%) were retained at three months. Of these, 203 (56%) were adherent. Records of infant testing were located for 204 women (42%). Women who were not retained were less likely to have an early infant diagnosis record (aOR ¼ 0.20; 95% CI: 0.10, 0.41). Among the women retained, there was a non-significant association between maternal adherence and infant testing (OR ¼ 1.35; 95% CI: 0.89, 2.06). Women lost at earlier continuum stages, who are at higher risk for mother-to-child-transmission, were less likely to bring infants for testing. Even with a test-and-treat program, many women did not remain in care or bring their infant for testing. Facilitating strategies to improve these measures remains an important unmet need.
Background
In July 2011, Malawi launched the ambitious Option Bþ program to improve prevention of mother-to-child transmission of HIV (PMTCT), decrease maternal morbidity and mortality, and prevent sexual transmission of HIV. 1 This approach calls for HIV-positive pregnant and breastfeeding women to start lifelong combination antiretroviral therapy (cART). Previously, Malawi's guidelines had called for cART initiation based on clinical stage or CD4 cell count. Challenges or delays in CD4 testing led to insufficient rates of cART initiation. 1 The initiation of Option Bþ precipitated a 748% increase in cART coverage for pregnant women with HIV. 1 In the ensuing years, the WHO recommended Option Bþ due to its capacity to promote maternal health and prevent transmission through a simple approach to treatment. 2 Many countries in sub-Saharan Africa have followed Malawi's lead and introduced this program. [3] [4] [5] [6] The long-term success of Option Bþ hinges on retaining women in care throughout the PMTCT continuum. In Malawi, this continuum begins when pregnant women are offered opt-out testing at their first antenatal care visit. Those who test HIV-positive are immediately offered cART to improve treatment accessibility by offering same-day treatment in the Antenatal Clinic (ANC). 1 Women are scheduled for monthly follow-up for the first six months, and then, if their retention and adherence are good, every two months. Infants return for an initial polymerase chain reaction (PCR) test for the presence of viral DNA six weeks after birth. If results are positive, infants then initiate cART immediately and are scheduled for monthly follow-up. HIV-negative infants are started on cotrimoxazole preventative therapy, and follow-up continues through breastfeeding.
Maternal loss to follow-up (LTFU) can occur at any point along this PMTCT continuum of care. The first month is especially vulnerable. [3] [4] [5] 7 Women who start Option Bþ during pregnancy have five times the odds of never returning after their first clinic visit compared to women who start cART based on clinical stage or CD4 cell count. 7 At a regional level, there are high levels of variation in Option Bþ retention. [3] [4] [5] [6] [7] [8] [9] Large, urban healthcare centres tend to have lower retention levels, as do programs where women initiate cART at ANC rather than a separate ART clinic. 7, 10 Among infants born to HIV-infected mothers who undergo early infant detection testing, HIV prevalence is low, but a substantial proportion of HIV-exposed infants do not receive this testing.
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Women who do not have a continued supply of cART are more likely to transmit HIV to their infants. 15 Additionally, these may be the very same women who do not return for the early infant diagnosis visit, which would result in a failure to test some of the infants most likely to be HIV-infected. Most previous examinations of infant retention have not analysed the relationship between maternal retention in care and return for infant testing, and the relationship between the two is not well established.
In this study, we characterise a portion of the PMTCT continuum of care. We focus on those who initiated cART and assess return for a first follow-up visit, retention for three months, and return for infant testing. We also aim to determine the factors associated with retention at each of these steps. We hypothesise that the women who progress further along the continuum will be more likely to return for infant testing.
Methods

Study setting
This retrospective cohort study examined records from the antenatal and under-five units at Bwaila Hospital. Bwaila is a district-level maternity hospital in Lilongwe, Malawi's capital, and it is the largest maternity unit in the country. The ANC serves as the initial point of contact with these women. All patients presenting for their first antenatal visit without a confirmed positive HIV test undergo opt-out HIV testing and counselling (HTC) with rapid tests by trained counsellors. Women undergo HTC either alone or with a partner. Individual HTC involves group pretest counselling with other pregnant women, opt-out testing, individual receipt of results, and individual post-test counselling. Couple HTC involves group pretest counselling with other couples, opt-out testing, receipt of results as a couple, and couple post-test counselling. HIV-positive pregnant women were encouraged to initiate cART on the day of testing in accordance with Malawi's Option Bþ guidelines. 1 During the study period, HTC was not a routine component of subsequent antenatal visits. At the time of this study, some women with CD4 > 500 elected to enrol in an ongoing study (PROMISE, NCT01253538) rather than continuing along the standard continuum of care, and they were excluded from our analysis. Women who initiated cART were scheduled for an initial follow-up visit after one month, with subsequent monthly follow-up visits. At each visit, a pill count was conducted by clinical staff. Women were told to bring their infants back to Bwaila's Family Health Unit for early infant diagnosis six weeks after giving birth in order to test the child for HIV.
Study population
The study population consisted of women who tested HIV-positive at their first visit at Bwaila ANC during the six-month period from 19 July 2013 to 18 January 2014 and had a record of cART initiation. HIV-negative women were excluded, as were women who had previously initiated cART, and women who opted to enrol in PROMISE. Women who had previously tested HIV-positive but had not yet initiated cART were included in this analysis; however, most women had not previously tested HIV-positive.
Data sources, abstraction, linkage
We used three data sources: HTC registers, HIV mastercards containing records of cART initiation and follow-up, and early infant diagnosis logs. Nurses or counsellors recorded HTC results for women and their partners in the HIV Rapid Testing and Counselling Registers (HTC registers), which included information about visit date, age, self-reported previous HIV test results, time since last HIV test, the presence of a male partner, and partner HIV status. HIV mastercard records include the date of cART initiation, the dates of subsequent visits, and patient adherence at each visit based on provider pill count. Early infant diagnosis PCR test logs contain infant dates of birth, maternal names, and HIV test results for infants brought back to Bwaila ANC at six weeks after birth.
Data were abstracted from the paper HTC registers and early infant detection logs in May and June of 2014. A Microsoft Access database was constructed to store the information and entered by a trained research assistant. cART clinic records were abstracted on 18 June 2014 from the electronic medical records system (EMRS). 16 Based on the names and ages of the HIV-positive mothers, as well as dates of presentation, a trained research assistant matched records in the HTC register with infant records in the early infant detection logs and maternal cART clinic records. Infant records were matched based on maternal name and included all infants born between September 2013 and June 2014.
Factors of interest
The population of HIV-positive women was characterised on the basis of age categories (15-25 years, 26-30 years, >30 years), last HIV test result, time since last HIV test, and partner HIV status. Time since last HIV test was recorded by providers as <24 months, 24 months, or unknown. HTC categories were individual, concordant couple, discordant couple, and unknown.
Outcomes
Continuum-related outcomes included having at least one cART follow-up visit (''first follow-up'') and retention in follow-up for three months (''three-month retention'') from the initial cART visit. Women were considered to have defaulted if they did not return within 60 days after their last scheduled follow-up visit in accordance with national policy. There were no instances of women reporting for a late follow-up visit more than 60 days after their last scheduled followup visit. The three-month period was chosen because almost all women would be expected to have at least three visits before the six-week infant testing visit. Information regarding pregnancy stage at the time of cART initiation was not available, but nurses estimated that most women first visited the ANC four to five months into their pregnancy. Even accounting for women whose initial ANC visit occurred several months later, at least three months should have elapsed between initiating cART and the six-week infant testing visit. This timing was chosen to ensure that the exposure (cART retention) preceded the outcome (attendance at the infant six-week visit). The three-month period is also equivalent to the amount of time that would have to elapse for a woman to be considered as having defaulted if she never returned for a followup visit. The presence or absence of an infant HIV DNA PCR testing record in the Early Infant Detection Logs (''infant return'') was also examined.
Adherence was assessed as a secondary outcome. Full adherence at a given time point was defined as presentation at each monthly visit up to and including that time point with at least 95% adherence at each of these visits. Adherence was measured based on pill count recorded by a nurse at each follow-up visit.
Analytical methods
We used unadjusted and adjusted logistic regression models to analyse factors of interest associated with first follow-up, three-month retention, and infant return. Factors associated with progression to each continuum step were examined only within the group of women who had progressed to the previous step, and factors associated with infant return were examined for all women. The adjusted model was controlled for age, an a priori confounder. Missing data were minimal and dropped from our analysis. Nine women had missing partner HIV status information and were dropped from related analyses ( Table 1) . Six of these women had received cHTC, while three underwent individual HTC (Table 1) . Three women had missing adherence data and were dropped from adherence analyses. Analyses were performed using Stata 13.0 (StataCorp, College Station, Texas). Associations were considered statistically significant if the p-value was less than 0.05.
A Kaplan-Meier survival curve was constructed to describe retention in care among those who initiated cART. Survival was defined as being alive and on treatment at a given time. Women who were lost to followup were given a failure time of their last scheduled visit. Women who were retained were censored on the day of their last visit or after 12 months of follow-up post-cART initiation. Women who died or stopped treatment were given a failure time of the day of the recorded event. Women who formally transferred to another clinic (N ¼ 12, 2%) were not included in this analysis.
Ethical approvals
These analyses received approval from the Malawian National Health Sciences Research Committee and the University of North Carolina at Chapel Hill IRB. Because all data were routinely collected and used anonymously, the need to obtain informed consent from study subjects was waived.
Results
Between 19 July 2013 and 18 January 2014, 7574 patients (6771 women and 803 male partners) were recorded in the HTC registers. At Bwaila ANC, almost all women received HTC during their first visit, unless they had previously tested HIV-positive. Overall, 578 women (8.6%) tested HIV-positive at Bwaila ANC on that day. The remaining 6193 women (91.4%) tested HIV-negative. Of the 578 HIV-infected women, 490 women (85%) had a cART initiation record, and nearly all of the remaining women were enrolled in the PROMISE study. This analysis was conducted among these 490 women.
Most women (79%) had tested previously, most (90%) presented without a partner, and approximately half (49%) did not know the HIV status of their partner (Table 1) . Their mean age at HTC was 26.2 (standard deviation ¼ 0.2). After initiating cART, 417 women (85%) returned for a first follow-up visit (Figure 1) .
Women who attended with a partner and received concordant test results had 2.19 times greater odds of returning for one-month follow-up (aOR ¼ 2.19; 95% CI: 0.50, 9.58; p ¼ 0.30) ( Table 2 ). Most women (N ¼ 356, 85%) were > 95% adherent to their pills.
Of the women retained at one month, 86% (360/417) were retained for at least three months, representing 73% (360/490) of all initiators (Figure 2) . The Kaplan-Meier survival curve reveals that LTFU occurs most notably among women who never return for a follow-up visit and among women who do not return for a second follow-up visit (Figure 2) . LTFU still continues after the three-month mark, with LTFU decreasing considerably over time (Figure 2) . Women who underwent HTC as part of a discordant couple had 1.73 times the odds of three-month retention compared to women who underwent individual HTC (95% CI: 0.57, 5.25; p ¼ 0.33) ( Table 3) . Of the 360 women with three-month retention, 203 (56%) achieved > 95% adherence over these three months (Figure 1 ). Three women with missing adherence data were dropped from the analysis. Half of the women with a first follow-up visit (N ¼ 203/417; 49%) had three followup visits with > 95% retention at each (Figure 1) .
Based on the early infant detection logs, 204 women (42%) had an infant record present, while 286 women (58%) did not. Compared to women who were retained for three months, women who defaulted right away (aOR ¼ 0.14; 95% CI: 0.07, 0.28; p < 0.001), and women who had a first follow-up visit but were not retained for three months (aOR ¼ 0.20; 95% CI: 0.10, 0.41; p < 0.001) were significantly less likely to exhibit infant return (Table 4) .
Among the 204 infants with an infant return record, only one infant tested HIV-positive. This infant was born to a mother who had tested HIV-negative less than 24 months prior to her first test, underwent individual HTC, and had a partner who she believed was HIV-negative. She initiated and then defaulted after four months of follow-up with imperfect adherence.
Discussion
Of the women who initiated cART, many returned for a follow-up visit, but some were lost. Only half of these women with a follow-up visit were retained with full adherence for three months, representing about a third of the total study population. Fewer than half of cART initiators returned to Bwaila for infant testing. Women lost at any step of the continuum were much less likely to have an infant testing record.
In Malawi, following the initiation of Option Bþ, about 24% of women were observed to be lost to follow-up within the first six months at facilities large enough to use the EMRS; most of this loss occurred within the first three months. 7 LTFU varies between 0% and 58% depending on the healthcare facility, with approximately 23.2% LTFU after 12 months at a national level. [7] [8] [9] Urban, Ministry of Health-managed central hospitals using EMRS, such as Bwaila, have the highest proportions of six-month LTFU. 7 Facilities that refer patients to ART clinics from ANC report higher retention than those where women receive cART at the ANC site and those where women receive their first dose of cART at the ANC site and continue in care elsewhere. 10 We observed lower retention than other studies in Malawi. Option Bþ retention within the entire country has been recorded at 77% over 12 months -retention in this study falls short of that metric even at three months. 1 However, 12-month retention defined by clinic attendance alone may not account for inconsistent attendance. 18 Additionally, post-Option Bþ infant PCR testing rates in Malawi have previously been reported at 86.5% as compared to 42% in this study. 11 Following the introduction of Option Bþ, other studies found that, while the percentage of women initiating cART increases considerably, the proportion of women who default immediately after this first visit is also high. 19 Likewise, this study still found a considerable amount of early LTFU among women initiating at Bwaila ANC.
These findings often exceed Option Bþ retention levels noted in other sites across sub-Saharan Africa. As compared to the 15% LTFU after a first visit observed in our study, investigations based in Mozambique (42.4%), Uganda (36.3%), and Ethiopia (28%) found notably higher LTFU after a woman's first visit. [3] [4] [5] This continuum of care falls short of the 90-90-90 targets -90% of HIV-infected persons aware of their HIV status, 90% of these persons retained in care, and 90% of these persons virally suppressed. 20 Of the women who initiated cART, only 73% were retained for at least three months, and only 56% of those women had full adherence. If full adherence is considered a proxy for viral suppression, this also falls short of the 90% benchmark. Full adherence has been associated with viral suppression following new initiation of cART. 21 However, three months with full adherence could be insufficient to achieve viral suppression in some women. It is also possible to falsify pill counts prior to follow-up visits to give a false impression of full adherence. Viral load data were not available in this study, which limits the capacity to establish whether women were virally suppressed. Even assuming 100% testing and cART initiation, 42% of women in this setting completed the outlined continuum of care, rather than 73% in a 90-90-90 scenario.
Women who initiate cART and adhere to treatment are more likely to return for infant testing. Similar Figure 2 . Kaplan-Meier survival curve showing retention in care among all HIV-positive women who initiated cART. Women at risk after a given length of retention in care is defined as the number of women still recorded to be in care at that point. This graph reflects all abstracted follow-up data. Women who did not return following initiation were given a follow-up time of 1 month as they were provided with sufficient medication for that time period. This accounts for the dramatic drop off at 1 month. These are women without a return visit.
findings have been noted in other parts of sub-Saharan Africa, but never in an Option Bþ setting or at an urban referral hospital. [22] [23] [24] Mothers adherent to a cART regimen are more likely to be virally suppressed, which decreases their likelihood of transmitting HIV to their child. 15 This group merits further characterization to optimise treatment protocols.
Mothers who are not on ARVs are less likely to be virally suppressed 25 and are consequently at higher risk of mother-to-child transmission. Therefore, the infants at highest risk of acquiring HIV are not presenting for early infant diagnosis. Infant prevalence in Lilongwe during Option Bþ has been documented between 2.6% and 5.7% at first PCR test, but additional transmission can occur during the postpartum period. 11, 13, 14 Failure to retain high-risk infants in care may explain low rates of infant HIV sero-positivity at first PCR test, and these may be severe underestimates of true infant HIV prevalence. This study is the first in the Option Bþ era to examine associations of each step in the continuum with exposed infants returning for early infant detection.
Women may have sought care elsewhere rather than discontinuing care-seeking altogether. Formal transfer events were recorded in the EMRS, but they were approximately 2%. Informal transfer occurs in the general cART program, and may account for some of the perceived LTFU in Option Bþ. 26 A study that traced patients lost to follow-up in this setting found that silent transfers were responsible for up to 25% of LTFU patients found alive. 27 A systematic review likewise noted that 18.6% of traced LTFU patients had self-transferred. 28 This likely explains some of the observed loss. Thus, PMTCT retention may be higher than single centre data suggest. 27 The discrepancy between previously reported post-Option Bþ infant PCR testing rates and those identified in this study further supports this possibility.
11 Similar analyses performed in more localised clinics within Lilongwe with improved coordination of care indicate that the low proportion of mothers linked to an infant PCR testing record likely represents both a lack of centralised record keeping across various health centres and, to a lesser extent, a lack of infant testing. 11 A centralised EMRS, system-wide unique identifier, or a more thorough system of recording transfers would be required to evaluate the continued follow-up of these informal transfers.
Linking records was a challenge. Each HTC record was linked by hand to the corresponding entries in the Women who underwent HTC with a partner and learned that they were HIV-discordant displayed a non-significant association with increased retention at three months as compared to women who underwent individual HTC. This is possibly due to partner support or understanding treatment as prevention. 25 Women who underwent HTC as a concordant couple displayed a non-significant association with having higher odds of a first follow-up visit. This finding fits with previous research regarding the continuum of care among women in concordant couples. [29] [30] [31] A substantial proportion of women are lost to follow-up along each step of the continuum of care. Therefore, interventions to help transition women between steps -or trace them when they transferare urgently needed. Various community and clinic interventions have the potential to reduce loss to follow-up at each point in the continuum, [32] [33] [34] [35] and results from several interventions implemented thus far appear promising. [36] [37] [38] [39] These approaches focus on mother-infant pair clinics, SMS messaging, male partner and community engagement, and clinic-or community-based peer support as strategies to improve retention in care among both mother and infant populations. [36] [37] [38] Both clinic-and community-based peer support are associated with improved maternal uptake and retention, as are integrating mother-infant care and engagement with male partners and the community. 38, 39 A completed investigation of retention in this clinic has found cHTC to be associated with improved one-month follow-up, supporting the use of engaging male partners to encourage HIV-positive pregnant women to have cHTC. 40 Although Option Bþ has been an important step forward for PMTCT in sub-Saharan Africa, further interventions are required to ensure that resources are applied with maximum efficacy to protect women and infants.
